Search Results - "Korhonen, Maarit J"

Polypharmacy Status as an Indicator of Mortality in an Elderly Population by Jyrkkä, Johanna, Enlund, Hannes, Korhonen, Maarit J., Sulkava, Raimo, Hartikainen, Sirpa

“…Background Increased use of drugs has raised concern about the risks of polypharmacy in elderly populations. Adverse outcomes, such as hospitalizations and…”
Get full text

Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study by Korhonen, Maarit J, Pentti, Jaana, Hartikainen, Juha, Ilomäki, Jenni, Setoguchi, Soko, Liew, Danny, Kivimäki, Mika, Vahtera, Jussi

“…Background Lifestyle modification is a key component of cardiovascular disease prevention before and concurrently with pharmacologic interventions. We…”
Get full text

Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study by Aarnio, Emma, Huupponen, Risto, Martikainen, Janne, Korhonen, Maarit J.

“…Vitamin K antagonists, warfarin in particular, have been the mainstay of anticoagulation therapy, but their use has declined in many countries since direct…”
Get full text

Statins and hip fracture prevention--a population based cohort study in women by Helin-Salmivaara, Arja, Korhonen, Maarit J, Lehenkari, Petri, Junnila, Seppo Y T, Neuvonen, Pertti J, Ruokoniemi, Päivi, Huupponen, Risto

“…To study the association of long-term statin use and the risk of low-energy hip fractures in middle-aged and elderly women. A register-based cohort study…”
Get full text

Mercury, Fish Oils, and Risk of Acute Coronary Events and Cardiovascular Disease, Coronary Heart Disease, and All-Cause Mortality in Men in Eastern Finland by Virtanen, Jyrki K, Voutilainen, Sari, Rissanen, Tiina H, Mursu, Jaakko, Tuomainen, Tomi-Pekka, Korhonen, Maarit J, Valkonen, Veli-Pekka, Seppänen, Kari, Laukkanen, Jari A, Salonen, Jukka T

“…OBJECTIVE—Mercury has been suggested to have negative effects on cardiovascular health. We investigated the effects of high mercury content in hair on the risk…”
Get full text

Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services by Hendrix, Ivanka, Page, Amy T., Korhonen, Maarit J., Bell, J. Simon, Tan, Edwin C. K., Visvanathan, Renuka, Cooper, Tina, Robson, Leonie, Sluggett, Janet K.

“…Aim While proton pump inhibitors (PPIs) are generally considered safe and well tolerated, frail older people who take PPIs long term may be susceptible to…”
Get full text

Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults: A Systematic Review and Meta-analysis by Ofori-Asenso, Richard, Chin, Ken L, Mazidi, Mohsen, Zomer, Ella, Ilomaki, Jenni, Zullo, Andrew R, Gasevic, Danijela, Ademi, Zanfina, Korhonen, Maarit J, LoGiudice, Dina, Bell, J Simon, Liew, Danny

“…Frailty is a common geriatric syndrome of significant public health importance, yet there is limited understanding of the risk of frailty development at a…”
Get full text

Long-term persistence with statin therapy: A nationwide register study in Finland by Helin-Salmivaara, Arja, MD, PhD, Lavikainen, Piia, MSc, Korhonen, Maarit J., LicSc (Pharm), PhD (Epid), Halava, Heli, MD, Junnila, Seppo Y.T., MD, PhD, Kettunen, Raimo, MD, PhD, Neuvonen, Pertti J., MD, PhD, Martikainen, Jaana E., LicSc (Pharm), Ruokoniemi, Päivi, MD, Saastamoinen, Leena K., PhD (Pharm), Virta, Lauri, MD, PhD, Huupponen, Risto, MD, PhD

“…Abstract Background: Preventive statin therapy is often recommended as lifelong treatment. Objective: The aim of this study was to analyze persistence with…”
Get full text

Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction by Korhonen, Maarit J., Robinson, Jennifer G., Annis, Izabela E., Hickson, Ryan P., Bell, J. Simon, Hartikainen, Juha, Fang, Gang

“…Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARB), beta-blockers and statins are recommended after acute myocardial…”
Get full text

Patterns of Drug Use and Factors Associated with Polypharmacy and Excessive Polypharmacy in Elderly Persons: Results of the Kuopio 75+ Study: A Cross-Sectional Analysis by Jyrkkä, Johanna, Enlund, Hannes, Korhonen, Maarit J., Sulkava, Raimo, Hartikainen, Sirpa

“…Background Although the increasing use of drugs in elderly persons has raised many concerns in recent years, the process leading to polypharmacy (PP) and…”
Get full text

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter? by Aarnio, Emma, Martikainen, Janne, Winn, Aaron N, Huupponen, Risto, Vahtera, Jussi, Korhonen, Maarit J

“…Previous research shows that low socioeconomic position (SEP; especially low income) is associated with statin nonadherence. We investigated the relationship…”
Get full text

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research by Aarnio, Emma, Huupponen, Risto, Martikainen, Jaana E., Korhonen, Maarit J.

“…Since 1994, the Finnish Prescription Register (FPR) has been the main data source for pharmacoepidemiology research in Finland. However, the FPR data are…”
Get full text

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence – Estimates from the Finnish prescription register by Aarnio, Emma, Korhonen, Maarit J, Huupponen, Risto, Martikainen, Janne

“…Abstract Objective To estimate the cost-effectiveness of statin therapy for primary prevention of coronary heart disease (CHD) events under real-world…”
Get full text

Odour annoyance and physical symptoms among residents living near waste treatment centres by Aatamila, Marjaleena, Verkasalo, Pia K., Korhonen, Maarit J., Suominen, Anna Liisa, Hirvonen, Maija-Riitta, Viluksela, Marja K., Nevalainen, Aino

“…Waste treatment processes produce odours and biological emissions to the environment, but their health effects are controversial. The aim of our study was to…”
Get full text

Frailty and Co-Prescribing of Potentially Interacting Drugs in New Users of Warfarin by Hauta-aho, Milka, Teperi, Simo, Korhonen, Maarit J., Bell, J. Simon, Farinola, Nicholas, Johns, Sally, Shakib, Sepehr, Huupponen, Risto

“…Background Warfarin is underutilised in frail older people because of the fear of bleeding complications. Drug interactions are an independent bleeding risk…”
Get full text

Healthcare Resource Utilization and Associated Costs During the First 5 Years After Diagnosis and at the End of Life: A Nationwide Cohort Study of Patients with Multiple Myeloma in Finland by Kosunen, Mikko, Ruotsalainen, Jarno, Kallio, Alvar, Metsä, Roope, Raittinen, Paavo, Lehmus, Leena, Korhonen, Maarit J, Purmonen, Timo

“…The burden associated with the treatment of patients with multiple myeloma (MM) is expected to increase due to the aging population. Thus, policymakers and…”
Get full text

Physicians’ views on patient participation in choice of oral anticoagulants in atrial fibrillation—a qualitative study by Aarnio, Emma, Huupponen, Risto, Hämeen‐Anttila, Katri, Merikoski, Merja, Puhakka, Jaana, Korhonen, Maarit J.

“…Direct oral anticoagulants provide an alternative to vitamin K antagonists for the anticoagulation therapy in atrial fibrillation (AF). The availability of…”
Get full text

Impact of Restricted Reimbursement on the Use of Statins in Finland: A Register-Based Study by Martikainen, Jaana E., Saastamoinen, Leena K., Korhonen, Maarit J., Enlund, Hannes, Helin-Salmivaara, Arja

“…Objectives: New and expensive medicines are a driving force behind growth in medicine costs, and policies promoting use of less expensive products have been…”
Get full text

Selective prescribing of statins and the risk of mortality, hospitalizations, and falls in aged care services by Korhonen, Maarit J., Ilomäki, Jenni, Sluggett, Janet K., Brookhart, M. Alan, Visvanathan, Renuka, Cooper, Tina, Robson, Leonie, Bell, J. Simon

“…Compared to randomized controlled trials, nonexperimental studies often report larger survival benefits but higher rates of adverse events for statin use vs…”
Get full text

Statin adherence and the risk of major coronary events in patients with diabetes: a nested case–control study by Ruokoniemi, Päivi, Korhonen, Maarit J., Helin‐Salmivaara, Arja, Lavikainen, Piia, Jula, Antti, Junnila, Seppo Y. T., Kettunen, Raimo, Huupponen, Risto

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Statin therapy is recommended in diabetes to lower the risk of coronary events. However, large randomized trials of…”
Get full text